Abate As Industries Ltd

Abate As Indust Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Abate As Industries Ltd

₹ 10.5 -0.38%
04 Jun - close price
abateas.com BSE: 531658
About

Incorporated in 1991, Abate As Industries
Ltd primarily operates in the eye healthcare segment through its super specialty hospitals
and optical outlets[1]

Key Points

Business Overview:[1]
AAIL is a multi-sector enterprise with a diverse portfolio in healthcare, education, retail, technology, real estate, and consultancy
services.

Website BSE
  • Market Cap ₹ 165 Cr.
  • Current Price ₹ 10.5
  • High / Low ₹ 26.2 / 9.26
  • Stock P/E 13.4
  • Book Value ₹ 11.0
  • Dividend Yield 0.00 %
  • ROCE 6.70 %
  • ROE 7.30 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Stock is trading at 0.95 times its book value
  • Debtor days have improved from 245 to 59.2 days.
  • Company's working capital requirements have reduced from 357 days to 75.1 days

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding is low: 32.4%
  • Tax rate seems low

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
0.00 0.00 0.00 14.09 41.06 42.13 42.69 33.94
0.04 0.03 0.02 13.28 38.56 38.28 38.76 30.84
Operating Profit -0.04 -0.03 -0.02 0.81 2.50 3.85 3.93 3.10
OPM % 5.75% 6.09% 9.14% 9.21% 9.13%
0.00 0.00 0.00 0.97 0.51 1.13 0.06 0.53
Interest 0.00 0.00 0.00 0.06 0.11 0.17 0.15 0.13
Depreciation 0.00 0.00 0.00 0.55 0.49 0.52 0.52 0.52
Profit before tax -0.04 -0.03 -0.02 1.17 2.41 4.29 3.32 2.98
Tax % 0.00% 0.00% 0.00% -1.71% 6.64% 5.13% 8.43% 2.01%
-0.04 -0.03 -0.02 1.19 2.25 4.07 3.06 2.93
EPS in Rs -0.04 -0.03 -0.02 0.08 0.14 0.26 0.19 0.19
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025 Mar 2026
14 159
13 146
Operating Profit 1 13
OPM % 5% 8%
1 3
Interest 0 1
Depreciation 1 2
Profit before tax 1 13
Tax % -2% 5%
1 12
EPS in Rs 0.07 0.78
Dividend Payout % 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 1031%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 1018%
Stock Price CAGR
10 Years: 24%
5 Years: 20%
3 Years: 6%
1 Year: 4%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 7%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025 Mar 2026
Equity Capital 79 158
Reserves 85 16
11 10
31 40
Total Liabilities 206 223
149 150
CWIP 0 0
Investments 14 14
43 59
Total Assets 206 223

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025 Mar 2026
-1 6
-162 -3
165 -2
Net Cash Flow 2 1
Free Cash Flow -1 3
CFO/OP -91% 57%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025 Mar 2026
Debtor Days 430 59
Inventory Days 413 49
Days Payable 209 36
Cash Conversion Cycle 635 72
Working Capital Days 640 75
ROCE % 7%

Insights

In beta
Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Revenue from Operations (Trading/Consultancy Phase)
INR ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Contract Asset Receivables (representing active service engagements)
INR in '000s
Experience in Retail/Wholesale (Sky International Subsidiary)
Years
Number of Fully Functional Eye Hospitals
Number
Number of Optical LLPs/Distribution Points
Number
Strategic Target for International Eye Hospitals
Number
Students Educated (BSc Optometry Program cumulative since 2005)
Number
Trade Receivables Turnover
Times

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

3 Recently
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
31.87% 31.87% 31.87% 31.87% 31.87% 31.87% 31.87% 27.56% 27.57% 27.57% 27.57% 32.42%
68.12% 68.12% 68.14% 68.13% 68.13% 68.13% 68.14% 72.44% 72.43% 72.44% 72.44% 67.58%
No. of Shareholders 1,0911,0691,0501,0281,0101,0461,0501,0641,0502,4352,5803,030

Documents

Announcements

Annual reports

Concalls